Tianjin Zhongxin Pharmaceutical Analyst Reports

SGinvestors.io > SGX Listed Stock > TIANJIN ZHONG XIN PHARM GROUP (SGX:T14) > Analysts Say

SGX Listed Stock

TIANJIN ZHONG XIN PHARM GROUP (SGX:T14)



TIANJIN ZHONG XIN PHARM GROUP (SGX:T14) has changed the issuer name / code to TIANJIN PHARM DA REN TANG GRP (SGX:T14) with effect from 2022-05-24.

See TIANJIN PHARM DA REN TANG GRP (SGX:T14)'s analyst reports.


TIANJIN ZHONG XIN PHARM GROUP (SGX:T14) @ SGinvestors.io
USD ***.**
-----
Share Price as of: -
ISIN Code:
Market: SGX Mainboard
Sector / Industry: Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals


Tianjin Zhongxin Pharmaceutical Analyst Research ReportsTIANJIN ZHONG XIN PHARM GROUP Analyst Research Reports SGX Listed Tianjin Zhongxin Pharmaceutical (SGX:T14) Analyst Research Reports T14.SI Analyst Research Reports



View the latest analyst reports on SGX listed stocks & S-REITs @ Analysts Say > Stocks / REITs Research Reports
Analyst Report
Analysts Say
Tianjin Zhongxin Pharmaceutical Analyst Reports


Your Say



Analysts Say |
Research Reports On Stocks / REITs | Latest Price Target & Stock Rating | Price Target with Substantial Upside/Downside Potential |

SGX Market |

Business News & Market Updates |
Business Headlines & Market News | Market Updates By SGX My Gateway | SGX Listed Companies Announcements | Latest Share BuyBack On Market Transactions | Upcoming Dividends / Rights / Share Entitlements |

Stocks & REITs Listing |
SGX Listed Stocks | SGX Listed Stocks By Sector | SGX Listed REITs | SGX Listed REITs By Sector |

SGX Stock / REIT Search

Advertisement

Trust Bank Referral Code

Advertisement